Procter & Gamble Hygiene and Health Care (PGHH) Fundamentals 2026 — P/E 34.1x, Revenue Analysis | SniperIQ
Procter & Gamble Hygiene and Health Care (PGHH) is a India-listed Consumer Defensive company in Household & Personal Products with a market capitalization of ₹29,183 Crore, trading at ₹8995.85 on the BSE. This SniperIQ fundamentals page covers Procter & Gamble Hygiene and Health Care's valuation (P/E 34.1x, P/B 38.8x), profitability (net margin 20.0%), revenue (₹4,282 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Procter & Gamble Hygiene and Health Care's market cap?
Procter & Gamble Hygiene and Health Care (PGHH) has a market capitalization of approximately ₹29,183 Crore, trading at ₹8995.85 on the BSE. Market cap moves with the live share price.
What is Procter & Gamble Hygiene and Health Care's P/E ratio?
Procter & Gamble Hygiene and Health Care's trailing twelve-month P/E ratio is 34.1x, with a price-to-book (P/B) of 38.8x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Procter & Gamble Hygiene and Health Care?
Procter & Gamble Hygiene and Health Care runs a net profit margin of 20.0%, a gross margin of 63.4%, and an operating margin of 26.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Procter & Gamble Hygiene and Health Care generate?
Procter & Gamble Hygiene and Health Care reported revenue of ₹4,282 Crore for fiscal year 2026, with net income of ₹857 Crore and earnings per share (EPS) of 263.86. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Procter & Gamble Hygiene and Health Care pay a dividend?
Procter & Gamble Hygiene and Health Care offers a trailing dividend yield of about 2.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Procter & Gamble Hygiene and Health Care financially healthy?
Procter & Gamble Hygiene and Health Care carries a debt-to-equity ratio of 0.00x and a current ratio of 1.22x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Procter & Gamble Hygiene and Health Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Procter & Gamble Hygiene and Health Care (PGHH) the key facts are: market cap ₹29,183 Crore, P/E 34.1x, revenue ₹4,282 Crore, 52-week range 8723.05-14620.45. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Procter & Gamble Hygiene and Health Care's full fundamentals live
Get Procter & Gamble Hygiene and Health Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.